Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.3%

3 terminated/withdrawn out of 133 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

17%

22 trials in Phase 3/4

Results Transparency

0 of 27 completed trials have results

Key Signals

17 recruiting

Enrollment Performance

Analytics

N/A

46(47.9%)

Phase 2

21(21.9%)

Phase 3

13(13.5%)

Phase 4

9(9.4%)

Phase 1

5(5.2%)

Early Phase 1

2(2.1%)

96Total

N/A(46)

Phase 2(21)

Phase 3(13)

Phase 4(9)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (133)

Showing 20 of 133 trials

NCT07366255Not ApplicableCompleted

Safety and Efficacy of Tripalmitoleoylglycerol in the Treatment of Dermatitis

Role: lead

NCT07583888Phase 2Recruiting

VABu Conditioning in Elderly AML HSCT

Role: collaborator

NCT05524168Phase 2Active Not Recruiting

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT06767007Phase 2Recruiting

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Role: collaborator

NCT07541521Recruiting

RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC

Role: collaborator

NCT07528066Recruiting

Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

Role: collaborator

NCT07370519Phase 2Recruiting

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

Role: lead

NCT07488299Not ApplicableNot Yet Recruiting

The Effect of PPI on Endoscopic Treatment of WON: a Multicenter Randomized Controlled Trial.

Role: collaborator

NCT05888350Not ApplicableCompleted

Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough.

Role: collaborator

NCT05149365Phase 3Completed

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Role: collaborator

NCT07374614Recruiting

Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

Role: collaborator

NCT05061342Recruiting

Tumor Control, Treatment Toxicity, Quality of Life and Bio-Imaging Repository Databank (TQ-BIRD) for Cancer Patients

Role: collaborator

NCT07366229Phase 2Not Yet Recruiting

Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne

Role: lead

NCT07353216Recruiting

Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels

Role: collaborator

NCT07353749Phase 4Not Yet Recruiting

Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms

Role: collaborator

NCT06647732Phase 2Recruiting

Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)

Role: collaborator

NCT06524427Not ApplicableRecruiting

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

Role: collaborator

NCT07194200Phase 2Recruiting

Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial

Role: lead

NCT07266532Not ApplicableCompleted

Topical Lactobacillus Crispatus for Skin Barrier Dysfunction in Obesity

Role: lead

NCT07184905Not ApplicableCompleted

Oral Bifidobacterium Longum for Skin Barrier Dysfunction in Obesity

Role: lead